← Leaderboards
Pablo J Cagnoni
University Of Colorado Denver
$413,706
Attributed
$413,706
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$413,706 · 1
By mechanism
M01$413,706 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- V Michael Holers$38,234,826
- Elizabeth J Shpall$12,617,686
- John G. Gerber$1,597,914
- Ellen L Burnham$17,290,816
- Andrew S Kraft$21,224,247
Others in their field
Top investigators on “Yttrium”
- Edward A Neuwelt · Oregon Health And Science University$6,737,950
- Yuni K Dewaraja · University Of Michigan At Ann Arbor$4,629,229
- Stephen J Forma · City Of Hope/Beckman Research Institute$4,233,376
- Valerie Humblet · Collagen Medical, Llc$4,133,374
- Michael J. Welch · Washington University$3,141,001
- Benjamin P Warner · Icagen, Inc.$3,000,000
Research focus
YttriumClinical ResearchClinical Trial Phase IDosageDrug Screening /EvaluationHuman SubjectHuman Therapy EvaluationImmunoconjugatesMonoclonal AntibodyNeoplasm /Cancer PharmacologyPharmacokineticsBreast NeoplasmsNeoplasm /Cancer RadioimmunotherapyNeoplasm /Cancer ImmunotherapyNeoplasm /Cancer Radionuclide Therapy
Grant awards (5)
90Y HUMANIZED BRE3 IN PATIENTS WITH METASTATIC BREAST CANCER$190,747
M01 · FY2002 · RR
90Y HUMANIZED BRE3 IN PATIENTS WITH METASTATIC BREAST CANCER$190,747
M01 · FY2001 · RR
90Y HUMANIZED BRE3 IN PATIENTS WITH METASTATIC BREAST CANCER$0
M01 · FY2001 · RR
90Y HUMANIZED BRE3 IN PATIENTS WITH METASTATIC BREAST CANCER$32,212
M01 · FY2000 · RR
90Y HUMANIZED BRE3 IN PATIENTS WITH METASTATIC BREAST CANCER$0
M01 · FY2000 · RR